Chris Pak

Chris Pak

Company: Molecular Targeting Technologies

Job title: Chief Executive Officer & President

Seminars:

EvaThera: A Safe and Effective Targeted-Radiopharmaceutical Platform 4:30 pm

The EvaThera Platform: Extends blood half-life of novel targeting radiopharmaceutical enhances target uptake with low toxicity in non-target organ Improves therapeutic and diagnostic outcomes in SSTR2 and integrinRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.